Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma
Abstract Background Radiotherapy plays a major role in the management of high grade glioma. However, the radioresistance of glioma cells limits its efficiency and drives recurrence inside the irradiated tumor volume leading to poor outcome for patients. Stereotactic hypofractionated radiotherapy is...
Main Authors: | Julian Biau, Emmanuel Chautard, Leanne De Koning, Frank Court, Bruno Pereira, Pierre Verrelle, Marie Dutreix |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-017-0858-0 |
Similar Items
-
Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models
by: Julian Biau, et al.
Published: (2019-06-01) -
Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
by: Julian Biau, et al.
Published: (2019-10-01) -
Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
by: Dennis S. Metselaar, et al.
Published: (2021-04-01) -
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
by: Donatella Arpa, et al.
Published: (2021-03-01) -
Multifocal high-grade glioma radiotherapy safety and efficacy
by: Daniel Felix Fleischmann, et al.
Published: (2021-08-01)